Jump Financial’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
120,051
+23,851
+25% +$340K 0.01% 1038
2026
Q1
$1.62M Buy
+96,200
New +$1.72M 0.02% 743
2025
Q4
Sell
-12,814
Closed -$158K 1975
2025
Q3
$158K Buy
+12,814
New +$150K ﹤0.01% 1677
2024
Q2
Sell
-48,089
Closed -$821K 1857
2024
Q1
$821K Buy
+48,089
New +$756K 0.02% 907
2022
Q4
Sell
-12,000
Closed -$162K 1617
2022
Q3
$162K Buy
+12,000
New +$202K 0.01% 1384
2021
Q4
Sell
-7,400
Closed -$205K 1420
2021
Q3
$205K Buy
+7,400
New +$225K 0.01% 865
2020
Q4
Sell
-17,032
Closed -$260K 972
2020
Q3
$260K Buy
+17,032
New +$357K 0.05% 546

Other funds holding CLB

Jump Financial's CLB Position: Q2 2026 in Review

Jump Financial increased its Core Laboratories (CLB) stake by 25% in Q2 2026, buying an estimated $340K and bringing the position to 120,051 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #1038.

Jump Financial first reported a position in CLB in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.62M in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Jump Financial held 120,051 shares of Core Laboratories worth $1.4M as of Q2 2026.
  • Jump Financial bought 23,851 Core Laboratories shares in Q2 2026, an estimated $340K.
  • Core Laboratories made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1038 holding.
  • Jump Financial first reported a position in Core Laboratories in Q3 2020 and has held it in 7 quarters since.
  • Jump Financial's Core Laboratories position peaked at $1.62M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.